Inhibition of AChE and BChE has been shown to be a key target for effective management of AD by alleviating cholinergic deficiency and improving neurotransmission, and BBR has inhibitory effects on both AChE and BChE (Greig et al., 2005; Muñoz-Torrero, 2008). Here, ACHE is linked to Alzheimer disease.